The future of cytotoxic drugs lies in improving their efficacy while reducing their toxicity. Advances in targeted therapy and nanotechnology are promising, aiming to deliver cytotoxic agents directly to cancer cells, thus minimizing damage to healthy tissues. Ongoing research is also focused on understanding the genetic and molecular basis of cancer to develop more personalized treatment strategies.
